Saeed Bohlega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saeed Bohlega has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Khaled K. Abu-Amero
Glaucoma Research Chair, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
2 shared publications - Abdulrahman Alreshaid
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
1 shared publication - Abdulrahman Edris
Hera Hospital, Mecca, Saudi Arabia
1 shared publication - Ali Hellani
PGD laboratory, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
1 shared publication - Asmahan Al Shubili
Neurology Department, Ibn Sina Hospital, Kuwait
1 shared publication Donald R. McLean
1 shared publication
Latest Publications
- Open Access
- 1 January 2008
- Published by Springer Nature in BMC Research Notes
- Vol. 1 (1) , 16
Absence of mtDNA mutations in leukocytes of CADASIL patients
Ultrastructural and biochemical abnormalities of mitochondria have been reported in skeletal muscle biopsies of CADASIL patients with mutations in the NOTCH3 nuclear gene. Additionally, it was proposed that NOTCH3 gene mutations may predispose the mitochondrial DNA (mtDNA) to mutations.
- 1 January 2008
- Published by Springer Nature in BMC Research Notes
- Vol. 1 (1) , 16
Open AccessAbsence of mtDNA mutations in leukocytes of CADASIL patients
Ultrastructural and biochemical abnormalities of mitochondria have been reported in skeletal muscle biopsies of CADASIL patients with mutations in the NOTCH3 nuclear gene. Additionally, it was proposed that NOTCH3 gene mutations may predispose the mitochondrial DNA (mtDNA) to mutations.
- Open Access
- 9 November 2007
- Published by Springer Nature in BMC Medical Genetics
- Vol. 8 (1) , 67
CADASIL in Arabs: clinical and genetic findings
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is increasingly recognized as an inherited arterial disease leading to a step-wise decline and eventually to dementia. CADASIL is caused by mutations in NOTCH3 epidermal growth factor-like repeat that maps to chromosome 19. CADASIL cases have been identified in most countries of Western and Central Europe, the Americas, Japan, Australia, the Caribbean, South America, Tanzania, Turkey, South Africa and Southeast Asia, but not in Arabs. Methods: We studied three families from Saudi Arabia (Family A), Kuwait (Family B) and Yemen (Family C) with 19 individuals affected by CADASIL. Results: The mean age of onset was 31 ± 6 and the clinical presentation included stroke in 68%, subcortical dementia in 17% and asymptomatic leukoariosis detected by MRI in 15%. Migraine and depression were frequently associated, 38% and 68% respectively. The mean age of death was 56 ± 11. All NOTCH3 exons were screened for mutations, which revealed the presence of previously reported mutations c.406C>T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C. Conclusion: CADASIL occurs in Arabs, with clinical phenotype and genotype similar to that in other ethnic groups.
- 9 November 2007
- Published by Springer Nature in BMC Medical Genetics
- Vol. 8 (1) , 67
Open AccessCADASIL in Arabs: clinical and genetic findings
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is increasingly recognized as an inherited arterial disease leading to a step-wise decline and eventually to dementia. CADASIL is caused by mutations in NOTCH3 epidermal growth factor-like repeat that maps to chromosome 19. CADASIL cases have been identified in most countries of Western and Central Europe, the Americas, Japan, Australia, the Caribbean, South America, Tanzania, Turkey, South Africa and Southeast Asia, but not in Arabs. Methods: We studied three families from Saudi Arabia (Family A), Kuwait (Family B) and Yemen (Family C) with 19 individuals affected by CADASIL. Results: The mean age of onset was 31 ± 6 and the clinical presentation included stroke in 68%, subcortical dementia in 17% and asymptomatic leukoariosis detected by MRI in 15%. Migraine and depression were frequently associated, 38% and 68% respectively. The mean age of death was 56 ± 11. All NOTCH3 exons were screened for mutations, which revealed the presence of previously reported mutations c.406C>T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C. Conclusion: CADASIL occurs in Arabs, with clinical phenotype and genotype similar to that in other ethnic groups.
- 1 March 2004
- Vol. 25 (3) , 395-401
Neurobrucellosis: Clinical and Neuroimaging Correlation
BACKGROUND AND PURPOSE: Manifestation of nervous system involvement by neurobrucellosis, a treatable infection, is not well documented. We investigated patterns of nervous system involvement and determined if neuroimaging abnormalities correlated with clinical manifestations of neurobrucellosis.
- 1 March 2004
- Vol. 25 (3) , 395-401
Neurobrucellosis: Clinical and Neuroimaging Correlation
BACKGROUND AND PURPOSE: Manifestation of nervous system involvement by neurobrucellosis, a treatable infection, is not well documented. We investigated patterns of nervous system involvement and determined if neuroimaging abnormalities correlated with clinical manifestations of neurobrucellosis.